0000899243-20-003410.txt : 20200205
0000899243-20-003410.hdr.sgml : 20200205
20200205202226
ACCESSION NUMBER: 0000899243-20-003410
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200203
FILED AS OF DATE: 20200205
DATE AS OF CHANGE: 20200205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GIANAKAKOS ANASTASIOS
CENTRAL INDEX KEY: 0001413822
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37609
FILM NUMBER: 20580554
MAIL ADDRESS:
STREET 1: 333 ALLERTON AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MyoKardia Inc
CENTRAL INDEX KEY: 0001552451
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 455500552
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-741-0900
MAIL ADDRESS:
STREET 1: 333 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-03
0
0001552451
MyoKardia Inc
MYOK
0001413822
GIANAKAKOS ANASTASIOS
C/O MYOKARDIA, INC.
333 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
President and CEO
Common Stock
2020-02-03
4
S
0
4000
69.2692
D
87777
D
Common Stock
2020-02-03
4
S
0
1000
69.744
D
86777
D
Common Stock
225947
I
By Reporting Person's Trust 2
Common Stock
323526
I
By Reporting Person's Trust 3
Common Stock
12200
I
By Trust 1
Common Stock
12200
I
By Trust 2
Common Stock
12200
I
By Trust 3
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Represents the weighted average sale price of the shares sold ranging from $68.55 to $69.54 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Represents the weighted average sale price of the shares sold ranging from $69.57 to $69.94 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
/s/ Cynthia J. Ladd, as Attorney-in-Fact
2020-02-05